Metabolic syndrome secondary prevention

Metabolic syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Metabolic Syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Dietary Therapy
Physical Activity
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Tertiary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Metabolic syndrome secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Metabolic syndrome secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Metabolic syndrome secondary prevention
CDC on Metabolic syndrome secondary prevention
Metabolic syndrome secondary prevention in the news
Blogs on Metabolic syndrome secondary prevention
Directions to Hospitals Treating Metabolic syndrome
Risk calculators and risk factors for Metabolic syndrome secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Effective measures for the secondary prevention of metabolic syndrome include monitoring lipid levels every 6 weeks, serum aminotransferase and CK levels every 6 months. BP, blood glucose, and HbA1c should be checked every 3 months.

Secondary Prevention

Effective measures for the secondary prevention of metabolic syndrome include

• Monitoring lipid levels every 6 weeks until target levels are achieved and, once stable, every 6 months.
• Serum aminotransferase and CK levels should be measured before initiating statins, fibrates, ezetimibe, or niacin. They should be rechecked each time the medication dose is adjusted and monitored every 6 months once the dose is stable.
• BP, blood glucose, and HbA1c should be checked every 3 months.
• Waist circumference and BMI should be measured every month.